SCR-LIP-000319 · Claim · machine-readable JSON →

A 2022 CADTH update found zero randomized or controlled comparative trials of liposuction for lipedema and reported divergent guidelines: the UK NICE 2022 (IPG721) restricts liposuction to research contexts due to inadequate efficacy/safety data, while the US 2021 standard of care (Herbst et al.) recommends conservative treatment first and recognizes liposuction as the only technique to remove abnormal lipedema tissue, with both guidelines endorsing specialized multidisciplinary centers.

Emerging clinical association Evidence certainty: very low (GRADE)

Created: 2026-05-31 · Last updated: 2026-05-31

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31

Evidence over time

2022DOI:10.51731/cjht.2022.413 · context

Evidence (1)

Context (PECO)

Conditionlipedema
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log